AVIVA SCRIP DIVIDEND SCHEME -APPLICATION TO LIST SHARES.
Application has been made to The UK Listing Authority and The London Stock Exchange for 27,052,339 ordinary shares of 25 pence each to trade on The London Stock Exchange and to be admitted to The Official List. These shares will rank pari passu with the existing ordinary shares.
These ordinary shares are to be issued as a Scrip Dividend alternative to receiving a cash dividend in respect of the 2009 interim dividend and dealings are expected to commence on 17 November 2009.
Contact:-
Kirsty Cooper, Deputy Group Company Secretary
Telephone: +44 207 662 7510
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.